Sema4 Expands Disparity Study on Precision Oncology Care for Underserved Communities
The study aims to enables access to comprehensive genetic and genomic testing for advanced cancer patients in underserved communities.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Cancer |
The study aims to enables access to comprehensive genetic and genomic testing for advanced cancer patients in underserved communities.
Read MorePosted by Andy Lundin | Mar 18, 2022 | Digital Pathology |
This digital pathology platform can efficiently digitize pathology slides to meet the needs of pathologists, researchers, and clinicians.
Read MorePosted by Andy Lundin | Mar 17, 2022 | Infectious Diseases |
A randomized clinical trial doubled the rate of hepatitis C screenings among the patients for whom they’re recommended.
Read MorePosted by Andy Lundin | Mar 11, 2022 | Kidney Disease |
In 2010, scientists discovered that African Americans born with a certain gene have a higher risk for experiencing chronic kidney disease.
Read MorePosted by Andy Lundin | Mar 4, 2022 | Company News |
The new CEO aims to foster new growth drivers and deliver on the company’s global strategy through product development, M&A, and strategic alliances.
Read More